PLUS THERAPEUTICS INC - COM NEW (PSTV)

CUSIP: 72941H400

Q3 2022 13F Holders as of 30 Sep 2022

Share change
-31,364
SEC-reported price per share
$0.45
Number of holders
20
Value change
-$26,016
Number of buys
5
Number of sells
7

Security key

72941H400

Report period

Q3 2022

Institutions

20

Top holders

10

Ownership snapshot

Top reported holders of PSTV - PLUS THERAPEUTICS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Parkman Healthcare Partne...
Disclosed value leader
Parkman Healthcare Partne...
Comparable rows
0/15
Latest evidence
30 Jun 2022
13F Highest disclosed value: $828,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Parkman Healthcare Partners LLC has the largest disclosed position value at $828K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Parkman Healthcare Partners LLC's linked filing trail.
Disclosed position value Top 5
Parkman Healthcare Partners LLC $828K
VANGUARD GROUP INC $462K
Otter Creek Advisors, LLC $178K
GEODE CAPITAL MANAGEMENT, LLC $139K
MORGAN STANLEY $64K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Parkman Healthcare Partners LLC
13F
Company
13F
—
denominator unverified
$828,000
1,533,075 shares
— 30 Jun 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$462,000
855,264 shares
— 30 Jun 2022
Otter Creek Advisors, LLC
13F
Company
13F
—
denominator unverified
$178,000
330,168 shares
— 30 Jun 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$139,000
258,437 shares
— 30 Jun 2022
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$64,000
118,421 shares
— 30 Jun 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$56,000
104,418 shares
— 30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
20
Shares
3,547,093
Rows available
20
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
18
Q3 2022 holders
20
Holder diff
2
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .